The Covid-19 pandemic rapidly shifted how life science sales and marketing teams operated. Commercial teams needed to learn and change significantly to survive. Now that 2023 has arrived, it is prudent to apply everything we learned from this era to set up teams for commercial success in 2023 and brace for more economic change. In this webinar, you’ll get a chance to review four key areas where commercial teams can focus their energy in 2023 to boost marketing and sales plans.
Register now to watch and save this important webinar where the featured speakers give a 2023 market overview and discuss four key areas of focus for commercial team success:
Evolving sales performance metrics: As more complex therapies enter the market, learn how can sales teams can alter their compensation strategy to drive changes in market behaviour, such as a better support of diagnosis rates or supporting an increase in patient referrals.
Diversifying marketing campaigns with race and ethnicity insights: A discussion of health equity and the importance of diversity in commercial strategy. Here, the speakers will discuss how populations of color are consistently underrepresented in healthcare data use, and what can be done about the issue.
Connecting digital campaigns with in-person engagement for the highest impact: Since we’ve learned that HCPs prefer hybrid engagement models, the speakers will discuss a how to adopt a true omnichannel approach with case studies to support their findings.
Sharpening focus with real-time HCP and account targeting: Timely and relevant content is key to maximizing interactions and breaking through the noise. Register to learn about the cutting-edge targeting methods.
Meghana Sundaresan, Market Strategy and Innovation Lead, Commercial, Komodo Health
Meghana Sundaresan is the Market Strategy and Innovation Lead for Commercial at Komodo Health. She joined the Komodo Health team in 2020 after five years in healthcare and life sciences consulting, where she worked with several pharma and biotech organizations to design commercial strategies for launching therapies in the market as well as repositioning existing offerings to optimize growth. At Komodo, she continues to work closely with commercial teams to support critical needs for data and analytics across the organization. She is passionate about helping life sciences organizations unlock advanced data and analytical capabilities through powerful, easy-to-use technologies to maximize insight generation. Meghana holds a degree in chemical engineering from National Institute of Technology, Nagpur, India, and an MBA from UVA – Darden.
Vivian DeWoskin, VP, Strategy – Head of Life Sciences, Komodo Health
Vivian DeWoskin is the VP, Market Strategy and Innovation, Head of Life Sciences at Komodo Health. Vivian joined the Komodo Health team in 2019 after nearly a decade in life sciences consulting, where she supported biotech and pharmaceutical companies with commercial strategy across the entire product lifecycle. At Komodo, she continues to work closely with commercial teams to support critical needs for data and analytics across the organization. She is passionate about helping life sciences organizations innovate and enhance their capabilities in automated insight-generation solutions. Vivian holds a degree in neuroscience from Princeton University, and an MBA from Berkeley-Haas.
Who Should Attend?
- Commercial Operations
- Commercial Analytics
- Sales/Field Operations
- Business Development
What You Will Learn
Attendees will gain insights into:
- Top areas of focus for commercial success and how to leverage data and technology to support them
- How to build a more digital and personalized strategy
- The importance of leveraging race and ethnicity data in commercialization
Komodo Health is a technology platform company creating the new standard for real-world data and analytics by pairing the industry’s most complete view of patient encounters with enterprise software and machine learning that connects the dots between individual patient journeys and large-scale health outcomes. Across Life Sciences, payer, provider, and developers, we help our customers unearth patient-centric insights at scale — marrying clinical data with advanced algorithms and AI-powered software solutions to inform decision making, close gaps in care, address disease burden, and help the enterprise create a more cost-effective, value-driven healthcare system.